Table 3.
Antiproliferative activity (IC50 in µM) of chalcones (2–16) and dihydropyrazoles (17–31).
| Compound | DU-145 | Compound | DU-145 |
|---|---|---|---|
| 2 | 432 ± 2 | 17 | 351 ± 2 |
| 3 | 176 ± 2 | 18 | 119 ± 2 |
| 4 | 393 ± 2 | 19 | 327 ± 2 |
| 5 | 147 ± 2 | 20 | 149 ± 2 |
| 6 | 141 ± 2 | 21 | 134 ± 2 |
| 7 | 31 ± 2 | 22 | 262 ± 2 |
| 8 | 254 ± 2 | 23 | 206 ± 2 |
| 9 | 292 ± 1 | 24 | 257 ± 2 |
| 10 | 138 ± 2 | 25 | 131 ± 2 |
| 11 | 353 ± 2 | 26 | 271 ± 2 |
| 12 | 256 ± 2 | 27 | 211 ± 2 |
| 13 | 209 ± 2 | 28 | 173 ± 2 |
| 14 | 206 ± 2 | 29 | 162 ± 2 |
| 15 | 94 ± 2 | 30 | 84 ± 2 |
| 16 | 17 ± 1 | 31 | 32 ± 1 |
| Methotrexate | 11 ± 1 | ||
Data are presented as mean ± SD (n = 3). All the compounds and the standard were dissolved in dimethyl sulfoxide (DMSO), diluted with culture medium containing 0.1% DMSO. The control cells were treated with culture medium containing 0.1% DMSO.